This medication is a kinase inhibitor, prescribed for medullary thyroid cancer. It blocks the action of an abnormal protein that signals cancer cells to multiply.
Contraindicated in patients with congenital long QT syndrome.
PO- The recommended daily dose is 300 mg.
It comes as a tablet to take by mouth, with or without food.
• Caution should be exercised in patients with history of heart disease, irregular heartbeat, heart attack, liver or kidney impairment, lung or breathing problems, bleeding episodes, high blood pressure, abnormal blood electrolyte, underactive thyroid, skin disease, diarrhea, decrease in white blood cell levels and platelet levels; who are taking other medications, any allergy, during pregnancy and breastfeeding.
• It may cause tiredness, weakness, or blurred vision, do not drive a car or operate machinery while taking this medication.
• Avoid alcohol consumption.
• It may reduce platelet counts; avoid injury or bruising.
• Avoid exposure to sunlight.
• Monitor ECGs, liver, thyroid, and kidney function; blood pressure, blood sugar, blood electrolyte levels and complete blood cell counts regularly while taking this medication.
• Most Common :
Diarrhea, rash, acne, nausea, high blood pressure, headache, fatigue, decreased appetite, and abdominal pain.
• Skin : Dry Skin, photosensitivity, itching.
• Gastrointestinal : Vomiting, indigestion, decreased weight.
• Central Nervous System : Weakness, sleeplessness, depression, tiredness, weakness.
• Serious Effects: QT prolongation.
Avoid excess dosage.
Stored it at room temperature (25°C).
Subscribe to our Free Newsletters!